AC-33-YJ09_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 9-Methoxy-2-[2-methoxyethyl(methyl)amino]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one, Inhibitors of Signal Transduction Pathways;MAPKAP-K2 (MK2) Inhibitors targeting MAPKAPK2 (Novartis, 11290018)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/11290018
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the AC-33-YJ09_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value

decreased expression

Symbol Name Standardized Value
RPL11 ribosomal protein L11 -4.52501
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -2.12605
RBPJ recombination signal binding protein for immunoglobulin kappa J region -1.35876
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle -0.899068
GFM2 G elongation factor, mitochondrial 2 -0.548201
RXYLT1 ribitol xylosyltransferase 1 -0.448146
TOR1B torsin family 1, member B (torsin B) -0.343917
SPG21 spastic paraplegia 21 (autosomal recessive, Mast syndrome) -0.336563
WTAP Wilms tumor 1 associated protein -0.266592
SAV1 salvador family WW domain containing protein 1 -0.221988
LRRC37B leucine rich repeat containing 37B -0.207508